source
- Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pillPlus, news about Merck, MultiValent Biotherapies, Alvotech, enGene, Mirum, and Adaptive Biotechnologies. 💸 Eli Lilly acquires another pain biotech: The Indianapolis pharma giant has made its 11th…Endpoints · 1mo ago↗ source
- FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid OverdoseThe U.S. Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone product, Rextovy, a 4 milligram (mg) naloxone hydrochloride nasal spray for the emergen…fda press · 1mo ago↗ source
- UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancerGlioblastoma is notoriously good at evading the immune system, making it particularly resistant to immunotherapy, but now researchers may have found a clever workaround. Scientists at the Universit…